Hengfang Wu
- Cardiology and Cardiovascular Medicine top 10%
- Molecular Biology
- Physiology
- Biochemistry top 10%
- Surgery
- Co-authors
- Di YangJin‐an ZhangZhiping BianXiangjian ChenChunrong GuNigel LevensMichel FélétouPaul M. Vanhoutte
- Topics
- Mitochondrial Function and Pathology (4 papers)Cardiovascular Function and Risk Factors (3 papers)Cardiac Fibrosis and Remodeling (3 papers)
In The Last Decade
Hengfang Wu
20 papers receiving 588 citations
Peers
Comparison fields: 5 of 84
- Cardiology and Cardiovascular Medicine 224
- Molecular Biology 207
- Physiology 150
- Biochemistry 71
- Surgery 65
Countries citing papers authored by Hengfang Wu
This map shows the geographic impact of Hengfang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hengfang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hengfang Wu more than expected).
Fields of papers citing papers by Hengfang Wu
This network shows the impact of papers produced by Hengfang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hengfang Wu. The network helps show where Hengfang Wu may publish in the future.
Co-authorship network of co-authors of Hengfang Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Hengfang Wu. A scholar is included among the top collaborators of Hengfang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hengfang Wu. Hengfang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 29 | |
| 5 | 13 | |
| 6 | 7 | |
| 7 | 2 | |
| 8 | 3 | |
| 9 | 29 | |
| 10 | 9 | |
| 11 | 46 | |
| 12 | 60 | |
| 13 | 13 | |
| 14 | Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells. | 20 |
| 15 | 125 | |
| 16 | 40 | |
| 17 | 29 | |
| 18 | 10 | |
| 19 | [Reduced Ca2+ current in rat cardiomyocytes transfected with troponin I R145W mutation gene]. | 1 |
| 20 | 137 |
About Hengfang Wu
Hengfang Wu is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Complementary and alternative medicine, having authored 20 papers that have together received 591 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Cardiac Fibrosis and Remodeling (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (224 citations), Biochemistry (71 citations) and Complementary and alternative medicine (62 citations). Hengfang Wu has collaborated with scholars based in China and France. Frequent co-authors include Di Yang, Jin‐an Zhang, Zhiping Bian, Xiangjian Chen, Xiangjian Chen, Chunrong Gu, Nigel Levens, Michel Félétou, Paul M. Vanhoutte and Chantal M. Boulanger. Their work appears in journals such as Analytical Chemistry, British Journal of Pharmacology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.